ID   AT8B2_HUMAN             Reviewed;        1209 AA.
AC   P98198; B4E3P4; Q6NT69; Q7Z486; Q96I43; Q96NQ7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-APR-2003, sequence version 2.
DT   12-APR-2017, entry version 155.
DE   RecName: Full=Phospholipid-transporting ATPase ID;
DE            EC=3.6.3.1;
DE   AltName: Full=ATPase class I type 8B member 2;
DE   AltName: Full=P4-ATPase flippase complex alpha subunit ATP8B2;
GN   Name=ATP8B2; Synonyms=ATPID, KIAA1137;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), ALTERNATIVE SPLICING (ISOFORM
RP   4), AND TISSUE SPECIFICITY.
RC   TISSUE=Colon;
RX   PubMed=12880872; DOI=10.1016/S1388-1981(03)00107-0;
RA   Harris M.J., Arias I.M.;
RT   "FIC1, a P-type ATPase linked to cholestatic liver disease, has
RT   homologues (ATP8B2 and ATP8B3) expressed throughout the body.";
RL   Biochim. Biophys. Acta 1633:127-131(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 671-1209 (ISOFORMS 1/3).
RC   TISSUE=Cerebellum, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 447-1209 (ISOFORMS 1/3).
RC   TISSUE=Lung, Mammary gland, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 277-1209 (ISOFORMS 1/3).
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1112-1209 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   INTERACTION WITH TMEM30A, AND SUBCELLULAR LOCATION.
RX   PubMed=20947505; DOI=10.1074/jbc.M110.139006;
RA   van der Velden L.M., Wichers C.G., van Breevoort A.E., Coleman J.A.,
RA   Molday R.S., Berger R., Klomp L.W., van de Graaf S.F.;
RT   "Heteromeric interactions required for abundance and subcellular
RT   localization of human CDC50 proteins and class 1 P4-ATPases.";
RL   J. Biol. Chem. 285:40088-40096(2010).
RN   [9]
RP   INTERACTION WITH TMEM30A AND TMEM30B, AND SUBCELLULAR LOCATION.
RX   PubMed=20961850; DOI=10.1074/jbc.M110.139543;
RA   Bryde S., Hennrich H., Verhulst P.M., Devaux P.F., Lenoir G.,
RA   Holthuis J.C.;
RT   "CDC50 proteins are critical components of the human class-1 P4-ATPase
RT   transport machinery.";
RL   J. Biol. Chem. 285:40562-40572(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1175, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalytic component of a P4-ATPase flippase complex
CC       which catalyzes the hydrolysis of ATP coupled to the transport of
CC       aminophospholipids from the outer to the inner leaflet of various
CC       membranes and ensures the maintenance of asymmetric distribution
CC       of phospholipids. Phospholipid translocation seems also to be
CC       implicated in vesicle formation and in uptake of lipid signaling
CC       molecules (Probable). {ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + phospholipid(Side 1) = ADP +
CC       phosphate + phospholipid(Side 2).
CC   -!- SUBUNIT: Component of a P4-ATPase flippase complex which consists
CC       of a catalytic alpha subunit and an accessory beta subunit
CC       (Probable). The probable flippase ATP8B2:TMEM30A complex can form
CC       an intermediate phosphoenzyme in vitro. The interaction with
CC       TMEM30B is reported conflictingly. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20947505,
CC       ECO:0000269|PubMed:20961850}; Multi-pass membrane protein
CC       {ECO:0000255}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:20961850}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=TMEM30A, but not TMEM30B, is required for its
CC       export from endoplasmic reticulum to the plasma membrane.
CC       {ECO:0000269|PubMed:20961850}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P98198-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=P98198-2; Sequence=VSP_007302, VSP_007303;
CC       Name=3;
CC         IsoId=P98198-3; Sequence=VSP_037147;
CC       Name=4;
CC         IsoId=P98198-4; Sequence=VSP_037148, VSP_037149, VSP_037150;
CC   -!- TISSUE SPECIFICITY: Isoform 3 is ubiquitous, with highest
CC       expression in aorta, cerebellum and uterus.
CC       {ECO:0000269|PubMed:12880872}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type)
CC       (TC 3.A.3) family. Type IV subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH30288.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB70822.1; Type=Frameshift; Positions=364; Evidence={ECO:0000305};
CC       Sequence=BAG65556.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY302537; AAQ19027.1; -; mRNA.
DR   EMBL; AK054886; BAB70822.1; ALT_FRAME; mRNA.
DR   EMBL; AK304806; BAG65556.1; ALT_INIT; mRNA.
DR   EMBL; AL162591; CAH72858.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53205.1; -; Genomic_DNA.
DR   EMBL; BC007837; AAH07837.2; -; mRNA.
DR   EMBL; BC030288; AAH30288.1; ALT_INIT; mRNA.
DR   EMBL; BC069264; AAH69264.1; -; mRNA.
DR   EMBL; AB032963; BAA86451.1; -; mRNA.
DR   EMBL; AL137537; CAB70799.1; -; mRNA.
DR   CCDS; CCDS1066.1; -. [P98198-3]
DR   CCDS; CCDS41405.1; -. [P98198-4]
DR   PIR; T46381; T46381.
DR   RefSeq; NP_001005855.1; NM_001005855.1. [P98198-4]
DR   RefSeq; NP_065185.1; NM_020452.3. [P98198-3]
DR   RefSeq; XP_005245412.1; XM_005245355.2. [P98198-1]
DR   UniGene; Hs.435700; -.
DR   ProteinModelPortal; P98198; -.
DR   BioGrid; 121445; 13.
DR   IntAct; P98198; 2.
DR   STRING; 9606.ENSP00000357475; -.
DR   iPTMnet; P98198; -.
DR   PhosphoSitePlus; P98198; -.
DR   BioMuta; ATP8B2; -.
DR   DMDM; 30316371; -.
DR   MaxQB; P98198; -.
DR   PaxDb; P98198; -.
DR   PeptideAtlas; P98198; -.
DR   PRIDE; P98198; -.
DR   DNASU; 57198; -.
DR   Ensembl; ENST00000368487; ENSP00000357472; ENSG00000143515. [P98198-4]
DR   Ensembl; ENST00000368489; ENSP00000357475; ENSG00000143515. [P98198-3]
DR   GeneID; 57198; -.
DR   KEGG; hsa:57198; -.
DR   UCSC; uc001few.4; human. [P98198-1]
DR   CTD; 57198; -.
DR   GeneCards; ATP8B2; -.
DR   HGNC; HGNC:13534; ATP8B2.
DR   HPA; HPA046680; -.
DR   MIM; 605867; gene.
DR   neXtProt; NX_P98198; -.
DR   OpenTargets; ENSG00000143515; -.
DR   PharmGKB; PA25167; -.
DR   eggNOG; KOG0206; Eukaryota.
DR   eggNOG; COG0474; LUCA.
DR   GeneTree; ENSGT00870000136387; -.
DR   HOGENOM; HOG000202528; -.
DR   HOVERGEN; HBG050601; -.
DR   InParanoid; P98198; -.
DR   KO; K01530; -.
DR   OMA; EFFICIT; -.
DR   OrthoDB; EOG091G0139; -.
DR   PhylomeDB; P98198; -.
DR   TreeFam; TF300654; -.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   GenomeRNAi; 57198; -.
DR   PRO; PR:P98198; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143515; -.
DR   CleanEx; HS_ATP8B2; -.
DR   Genevisible; P98198; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004012; F:phospholipid-translocating ATPase activity; IBA:GO_Central.
DR   GO; GO:0007030; P:Golgi organization; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   Gene3D; 1.20.1110.10; -; 1.
DR   Gene3D; 2.70.150.10; -; 1.
DR   Gene3D; 3.40.1110.10; -; 2.
DR   InterPro; IPR030347; ATP8B2.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_domN.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006539; P-type_ATPase_IV.
DR   InterPro; IPR032631; P-type_ATPase_N.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR032630; P_typ_ATPase_c.
DR   PANTHER; PTHR24092; PTHR24092; 1.
DR   PANTHER; PTHR24092:SF98; PTHR24092:SF98; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   Pfam; PF16212; PhoLip_ATPase_C; 1.
DR   Pfam; PF16209; PhoLip_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 3.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   TIGRFAMs; TIGR01652; ATPase-Plipid; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Endoplasmic reticulum; Hydrolase; Lipid transport; Magnesium;
KW   Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   1209       Phospholipid-transporting ATPase ID.
FT                                /FTId=PRO_0000046365.
FT   TOPO_DOM      1     64       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     65     86       Helical. {ECO:0000255}.
FT   TOPO_DOM     87     92       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM     93    112       Helical. {ECO:0000255}.
FT   TOPO_DOM    113    295       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    296    317       Helical. {ECO:0000255}.
FT   TOPO_DOM    318    346       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM    347    368       Helical. {ECO:0000255}.
FT   TOPO_DOM    369    889       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    890    910       Helical. {ECO:0000255}.
FT   TOPO_DOM    911    922       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM    923    942       Helical. {ECO:0000255}.
FT   TOPO_DOM    943    972       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    973    994       Helical. {ECO:0000255}.
FT   TOPO_DOM    995   1008       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM   1009   1031       Helical. {ECO:0000255}.
FT   TOPO_DOM   1032   1037       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1038   1058       Helical. {ECO:0000255}.
FT   TOPO_DOM   1059   1078       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM   1079   1103       Helical. {ECO:0000255}.
FT   TOPO_DOM   1104   1209       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE    411    411       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   METAL       833    833       Magnesium. {ECO:0000250}.
FT   METAL       837    837       Magnesium. {ECO:0000250}.
FT   MOD_RES    1175   1175       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     29       MTVPKEMPEKWARAQAPPSWSRKKPSWGT -> MDTLRAVP
FT                                LFSISGLFSFPYRVSHGIAGILLGEMAVCAKKRPP (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:12880872}.
FT                                /FTId=VSP_037147.
FT   VAR_SEQ       1     29       MTVPKEMPEKWARAQAPPSWSRKKPSWGT -> MAVCAKKR
FT                                PP (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037148.
FT   VAR_SEQ     364    406       SVEVIRLGHSYFINWDKKMFCMKKRTPAEARTTTLNEELGQ
FT                                VE -> RYVPSLTWGLSRESGGPIELFFSMKMKSLRSNEKS
FT                                SSSCTVNI (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037149.
FT   VAR_SEQ     407   1209       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037150.
FT   VAR_SEQ     434    461       GDVFDVLGHKAELGERPEPVDFSFNPLA -> VGSEGPRRK
FT                                GPSWPGTVAHAYSHSTLGG (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_007302.
FT   VAR_SEQ     462   1209       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_007303.
FT   CONFLICT    834    834       G -> E (in Ref. 5; BAA86451).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1209 AA;  137440 MW;  D905A97E9D9724BD CRC64;
     MTVPKEMPEK WARAQAPPSW SRKKPSWGTE EERRARANDR EYNEKFQYAS NCIKTSKYNI
     LTFLPVNLFE QFQEVANTYF LFLLILQLIP QISSLSWFTT IVPLVLVLTI TAVKDATDDY
     FRHKSDNQVN NRQSQVLING ILQQEQWMNV CVGDIIKLEN NQFVAADLLL LSSSEPHGLC
     YIETAELDGE TNMKVRQAIP VTSELGDISK LAKFDGEVIC EPPNNKLDKF SGTLYWKENK
     FPLSNQNMLL RGCVLRNTEW CFGLVIFAGP DTKLMQNSGR TKFKRTSIDR LMNTLVLWIF
     GFLVCMGVIL AIGNAIWEHE VGMRFQVYLP WDEAVDSAFF SGFLSFWSYI IILNTVVPIS
     LYVSVEVIRL GHSYFINWDK KMFCMKKRTP AEARTTTLNE ELGQVEYIFS DKTGTLTQNI
     MVFNKCSING HSYGDVFDVL GHKAELGERP EPVDFSFNPL ADKKFLFWDP SLLEAVKIGD
     PHTHEFFRLL SLCHTVMSEE KNEGELYYKA QSPDEGALVT AARNFGFVFR SRTPKTITVH
     EMGTAITYQL LAILDFNNIR KRMSVIVRNP EGKIRLYCKG ADTILLDRLH HSTQELLNTT
     MDHLNEYAGE GLRTLVLAYK DLDEEYYEEW AERRLQASLA QDSREDRLAS IYEEVENNMM
     LLGATAIEDK LQQGVPETIA LLTLANIKIW VLTGDKQETA VNIGYSCKML TDDMTEVFIV
     TGHTVLEVRE ELRKAREKMM DSSRSVGNGF TYQDKLSSSK LTSVLEAVAG EYALVINGHS
     LAHALEADME LEFLETACAC KAVICCRVTP LQKAQVVELV KKYKKAVTLA IGDGANDVSM
     IKTAHIGVGI SGQEGIQAVL ASDYSFSQFK FLQRLLLVHG RWSYLRMCKF LCYFFYKNFA
     FTMVHFWFGF FCGFSAQTVY DQYFITLYNI VYTSLPVLAM GVFDQDVPEQ RSMEYPKLYE
     PGQLNLLFNK REFFICIAQG IYTSVLMFFI PYGVFADATR DDGTQLADYQ SFAVTVATSL
     VIVVSVQIGL DTGYWTAINH FFIWGSLAVY FAILFAMHSN GLFDMFPNQF RFVGNAQNTL
     AQPTVWLTIV LTTVVCIMPV VAFRFLRLNL KPDLSDTVRY TQLVRKKQKA QHRCMRRVGR
     TGSRRSGYAF SHQEGFGELI MSGKNMRLSS LALSSFTTRS SSSWIESLRR KKSDSASSPS
     GGADKPLKG
//
